Study of Dual Targeted CD19/BCMA FASTCART GC012F in Relapsed/ Refractory Multiple Myeloma
Clinical trial NCT05412329 · UNKNOWN
Trial details
- NCT number
- NCT05412329
- Sponsor
- Shanghai Changzheng Hospital
- Status
- UNKNOWN
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2022-06-13
- Primary completion
- 2024-06-01
- Enrollment
- 9
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.